Perry Siatis - AbbVie Gen VP
| ABBV34 Stock | BRL 64.75 0.64 0.98% |
Insider
Perry Siatis is Gen VP of AbbVie Inc
| Phone | 847 932 7900 |
| Web | https://www.abbvie.com |
AbbVie Management Efficiency
The company has return on total asset (ROA) of 0.0927 % which means that it generated a profit of $0.0927 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.7529 %, meaning that it generated $0.7529 on every $100 dollars invested by stockholders. AbbVie's management efficiency ratios could be used to measure how well AbbVie manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jason Gorevic | Teladoc Health | 51 | |
| Shirley Stacy | Align Technology | N/A | |
| Hae Kim | British American Tobacco | 49 | |
| Zelko Relic | Align Technology | 58 | |
| Courtney McLeod | Teladoc Health | N/A | |
| Xin Fan | Autohome | N/A | |
| George Brooks | Teladoc Health | N/A | |
| Stuart Hockridge | Align Technology | 51 | |
| Joseph Hogan | Align Technology | 66 | |
| Guy Meldrum | British American Tobacco | 51 | |
| Andrew Turitz | Teladoc Health | 50 | |
| Vamsi Pudipeddi | Align Technology | 51 | |
| Paul Lageweg | British American Tobacco | 53 | |
| Anita Chen | Autohome | N/A | |
| Simon Beard | Align Technology | 56 | |
| Kingsley Wheaton | British American Tobacco | 50 | |
| Jack Bowles | British American Tobacco | 59 | |
| Luciano Comin | British American Tobacco | 53 | |
| Sterling Song | Autohome | N/A | |
| Claus Jensen | Teladoc Health | N/A | |
| Adam Vandervoort | Teladoc Health | 48 | |
Management Performance
| Return On Equity | 0.75 | |||
| Return On Asset | 0.0927 |
AbbVie Inc Leadership Team
Elected by the shareholders, the AbbVie's board of directors comprises two types of representatives: AbbVie inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AbbVie. The board's role is to monitor AbbVie's management team and ensure that shareholders' interests are well served. AbbVie's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AbbVie's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Richard Gonzalez, Chairman of the Board, CEO | ||
| Perry Siatis, Gen VP | ||
| Thomas Hudson, VP Officer | ||
| Timothy Richmond, Senior Vice President - Human Resources | ||
| Laura Schumacher, Executive Vice President External Affairs, General Counsel and Corporate Secretary | ||
| Robert Michael, Vice President Controller | ||
| Elizabeth Shea, VP Relations | ||
| Azita SalekiGerhardt, Senior Vice President - Operations | ||
| Jeffrey Stewart, Senior Vice President U.S. Commercial Operations | ||
| Scott Reents, VP CFO |
AbbVie Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AbbVie a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.75 | |||
| Return On Asset | 0.0927 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.39 % | |||
| Current Valuation | 1.85 T | |||
| Shares Outstanding | 28.3 B | |||
| Price To Earning | 92.88 X | |||
| Price To Book | 18.25 X | |||
| Price To Sales | 26.35 X | |||
| Revenue | 58.05 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in AbbVie Stock
When determining whether AbbVie Inc is a strong investment it is important to analyze AbbVie's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AbbVie's future performance. For an informed investment choice regarding AbbVie Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.